|
|
||||||||
Animal: DNA Viruses |
LRF Virus Centre, Department of Veterinary Pathology, University of Glasgow, Bearsden Road, Glasgow G61 1QH, UK1
Department of Pathology, Santa Casa de São Paulo, São Paulo, CEP 01277, Brazil2
Department of Public Health Sciences, University of Edinburgh Medical School, Teviot Place, Edinburgh EH8 9AG, UK 3
MRC Virology Unit, Institute of Virology, University of Glasgow, Church Street, Glasgow G11 5JR, UK4
Author for correspondence: Jane MacKenzie.Fax +44 141 330 5733. e-mail j.mackenzie{at}vet.gla.ac.uk
EBNA-1 is the only viral protein consistently expressed in all cells latently infected by EpsteinBarr virus (EBV). There is a high frequency of sequence variation within functionally important domains of EBNA-1, with five subtypes identified. Individuals may be infected with multiple EBV strains (classified according to EBNA-1 subtype), but Burkitt's lymphoma (BL) tumours carry a single subtype and exhibit some subtype preference. Subtype variation has also been related to geographical location. In the present study EBNA-1 polymorphisms were examined in a series of haematological malignancies from two distinct geographical regions, Brazil and the United Kingdom. Nucleotide sequence analysis of the carboxy-terminal region of EBNA-1 in 34 cases revealed six distinct sequences, some of which are novel. A new subtype, named V-Ala, was identified. EBNA-1 subtype in tumours differed markedly according to geographical location. In contrast to previous studies, we found evidence of EBNA-1 sequence variation within individual BL tumour samples.
This article has been cited by other articles:
![]() |
J. Stebbing, T. Powles, M. Nelson, and M. Bower Significance of Variation Within HIV, EBV, and KSHV Subtypes. J Int Assoc Physicians AIDS Care (Chic Ill), September 1, 2006; 5(3): 93 - 102. [Abstract] [PDF] |
||||
![]() |
W.-Y. Wang, Y.-C. Chien, J.-S. Jan, C.-M. Chueh, and J.-C. Lin Consistent Sequence Variation of Epstein-Barr Virus Nuclear Antigen 1 in Primary Tumor and Peripheral Blood Cells of Patients with Nasopharyngeal Carcinoma Clin. Cancer Res., August 1, 2002; 8(8): 2586 - 2590. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |